THOLANDER , B.; KOLIADI , A.; BOTLING , J.; DAHLSTRAND , H.; VON HEIDEMAN , A.; AHLSTRÖM , H.; ÖBERG , K.; ULLENHAG , G. J. Complete response with combined BRAF and MEK inhibition in BRAF mutated advanced low-grade serous ovarian carcinoma. Upsala Journal of Medical Sciences, v. 125, n. 4, p. 325–329, 10 Oct. 2020.